Tempus Pixel vs A View LCS

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Tempus Pixel

by Tempus (formerly Arterys)

A View LCS

by Coreline Soft

AI Verdict

Tempus Pixel is a broader, multi-modality AI platform for general medical imaging analysis across cardiology, oncology, and neurology. A View LCS, conversely, is a highly specialized solution focused on comprehensive thoracic CT analysis, including lung cancer screening and detailed coronary artery calcification scoring. While both leverage AI for medical imaging and share some cardiology applications, their primary scope and depth of specialization differ, making them adjacent rather than direct competitors.

Choose Tempus Pixel if…

Choose Tempus Pixel if your institution requires a versatile, multi-modality AI imaging platform for a broad range of specialties including cardiology, oncology, and neurology. It is ideal for environments prioritizing real-time collaboration and advanced 3D visualization across MRI, CT, X-ray, and ultrasound images to enhance diagnostic accuracy and workflow efficiency.

View Tempus Pixel →

Choose A View LCS if…

Choose AVIEW LCS if your primary focus is comprehensive and specialized thoracic CT analysis, particularly for robust lung cancer screening programs. This tool excels in automating lung nodule detection, classification, and volume quantification, alongside detailed emphysema analysis and coronary artery calcification scoring from a single low-dose CT scan.

View A View LCS →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Tempus Pixel	A View LCS
Pricing	Contact for quote	Unknown
Deployment	Cloud-based, web-based (accessible via Google Chrome browser), integrates with existing PACS, EHR, and RIS environments.	Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker). It can also be integrated into standard reading environments (PACS), RIS (Radiological Information System), or used as a standalone third-party application or web-based application.
FDA Status	1 AI-estimated	1 AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tempus Pixel

Tempus Pixel emphasizes a cloud-based, web-based platform accessible via standard browsers and features real-time collaboration, suggesting a focus on broad accessibility and ease of use for clinicians. This approach promotes a streamlined and user-friendly workflow for diagnostic analysis.

Clinical Value

A View LCS

AVIEW LCS offers highly specialized and detailed AI-powered analysis for thoracic CT scans, including automated lung nodule detection with 3D quantification, Lung-RADS scoring, emphysema analysis, and comprehensive coronary artery calcification scoring. These specific, quantifiable features provide clear and deep clinical utility within its focused domain.

Pricing & Value

Tie

Both Tempus Pixel and AVIEW LCS require direct contact for pricing information, indicating a lack of public pricing transparency. Without specific cost details or further information on their respective value propositions, it is not possible to objectively compare them on this dimension.

Enterprise Readiness

A View LCS

Both tools are FDA-cleared and HIPAA compliant, essential for enterprise adoption. However, AVIEW LCS offers superior deployment flexibility, including cloud, hybrid, local hardware, and virtualized options, which caters to a wider range of enterprise IT infrastructures and security policies compared to Tempus Pixel's cloud-based, web-only deployment.

Innovation

A View LCS

While both leverage AI, AVIEW LCS demonstrates specific technical innovation with its 'CT kernel conversion AI technology,' which addresses a significant challenge in standardizing image analysis across different scanner types. Its highly specialized and detailed quantification features for thoracic conditions also showcase advanced AI application in a focused clinical area.

Support & Docs

Tie

The provided structured facts and general web searches do not offer specific details regarding the availability, scope, or quality of support and documentation for either Tempus Pixel or AVIEW LCS. Therefore, it is not possible to differentiate between the two on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Tempus Pixel	A View LCS
Name	Tempus Pixel	A View LCS
Company	Tempus (formerly Arterys)	Coreline Soft Co.
Description	Tempus Pixel is an AI-powered, cloud-based medical imaging analysis platform, originally by Arterys, that enhances diagnostic accuracy and workflow efficiency for radiologists and clinicians across cardiology, oncology, and neurology.	AVIEW LCS by Coreline Soft is an FDA-cleared AI-powered medical imaging platform for comprehensive thoracic CT analysis, specializing in lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan.
Key Specialties	Cardiology, Oncology, Radiology	Cardiology, Pulmonology, Radiology
Primary Focus/Key Features	AI-powered analysis, Cloud-based platform, Real-time collaboration, Multi-modality support (MRI, CT, X-ray, ultrasound), Automated reporting, 3D visualization, Quantitative analysis, DICOM compatibility	Automated lung nodule detection and classification, Nodule volume quantification and measurement (3D), Lung-RADS scoring and reporting, Emphysema analysis and quantification (LAA), Coronary Artery Calcium (CAC) scoring (Agatston, volume, mass), Segmentation of major coronary arteries, Automated comprehensive report generation (PDF, DICOM PDF, SR), CT kernel conversion AI technology

Videos

Demos, reviews, and walkthroughs featuring Tempus Pixel and A View LCS.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications and specialties supported by Tempus Pixel and A View LCS?

Tempus Pixel enhances diagnostic accuracy and workflow efficiency across cardiology, oncology, and neurology. A View LCS specializes in comprehensive thoracic CT analysis, focusing on lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan.

Which imaging modalities can each platform analyze?

Tempus Pixel offers multi-modality support, analyzing MRI, CT, X-ray, and ultrasound images. A View LCS is specifically designed for comprehensive thoracic CT analysis, primarily utilizing low-dose CT scans.

What specific AI-powered analyses do Tempus Pixel and A View LCS provide?

Tempus Pixel provides general AI-powered analysis, 3D visualization, and quantitative analysis. A View LCS offers automated lung nodule detection and classification, nodule volume quantification, Lung-RADS scoring, emphysema analysis, and comprehensive coronary artery calcium scoring (Agatston, volume, mass).

How do these tools integrate with existing hospital IT infrastructure?

Tempus Pixel integrates with existing PACS, EHR, and RIS environments. A View LCS generates automated comprehensive reports in PDF, DICOM PDF, and SR formats, which facilitates integration into existing systems.

What kind of reporting capabilities do these platforms offer?

Tempus Pixel provides automated reporting. A View LCS offers automated comprehensive report generation in PDF, DICOM PDF, and SR formats, including Lung-RADS scoring and detailed coronary artery calcium scoring.